Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Maravai LifeSciences Holdings Inc MRVI

Technology Scientific & Technical Instruments
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. The Company operates through two segments. Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acid products to support the needs of customer research, therapeutic and vaccine programs. The segment also provides research products for labeling and detecting proteins in cells and tissue samples. Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities.


NDAQ:MRVI - Post by User

Maravai LifeSciences Holdings Inc
Bullboard Posts
Next >>
User Avatar Image
(229)
•••
Post by whytestockson Feb 23, 2024 3:45pm
45 Views
Post# 35896380

Outperform Recommendation Issued On MRVI By William Blair

Outperform Recommendation Issued On MRVI By William Blair
NEWS: $MRVI Outperform Recommendation Issued On MRVI By William Blair2024-02-23 14:30:03 ET William Blair analyst issues OUTPERFORM recommendation for MRVI on February 23, 2024 02:07PM ET. The previous analyst recommendation was Outperform. MRVI was trading at $8.25 at issue of the analyst recommendation. The overall analyst consensus : B...MRVI - Outperform Recommendation Issued On MRVI By William Blair

Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities